Back
Aclaris Therapeutics Vs. BridgeBio Pharma Industry Stock Comparison
Sell
11
ACRS
Aclaris Therapeutics
Last Price:
1.25
Seasonality Move:
-2.56%
Sell
19
BBIO
BridgeBio Pharma
Last Price:
24.96
Seasonality Move:
8.74%
Sell
11
Aclaris Therapeutics (ACRS)
is a Sell
Is Aclaris Therapeutics a Buy, Sell or Hold?
- The current Aclaris Therapeutics [ACRS] share price is $1.23. The Score for ACRS is 11, which is 78% below its historic median score of 50, and infers higher risk than normal.
- ACRS is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
19
BridgeBio Pharma (BBIO)
is a Sell
Is BridgeBio Pharma a Buy, Sell or Hold?
- The current BridgeBio Pharma [BBIO] share price is $24.98. The Score for BBIO is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
- BBIO is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
ACRS Stock Price Chart
What is Aclaris Therapeutics's stock price today?
-
The Aclaris Therapeutics share price today is $1.23
The current trend is relatively stagnant and ACRS is experiencing slight buying pressure.
BBIO Stock Price Chart
What is BridgeBio Pharma's stock price today?
-
The BridgeBio Pharma share price today is $24.98
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BBIO is experiencing selling pressure, which indicates risk of future bearish movement.
ACRS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0 | Sell |
| Relative Strength Index (14 RSI): | 52.24 | Buy |
| Chaikin Money Flow: | -52807 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.16 - 1.24) | Buy |
| Bollinger Bands (100): | (1.02 - 1.26) | Buy |
BBIO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.37 | Sell |
| Relative Strength Index (14 RSI): | 30.66 | Sell |
| Chaikin Money Flow: | -994606 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (26.8 - 29.76) | Sell |
| Bollinger Bands (100): | (29.01 - 37.87) | Sell |
ACRS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.2 | Buy |
| 20-day SMA: | 1.21 | Buy |
| 50-day SMA: | 1.22 | Buy |
| 200-day SMA: | 4.1 | Sell |
| 8-day EMA: | 1.21 | Buy |
| 20-day EMA: | 1.21 | Buy |
| 50-day EMA: | 1.27 | Sell |
| 200-day EMA: | 3.8 | Sell |
BBIO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 26.91 | Sell |
| 20-day SMA: | 28.38 | Sell |
| 50-day SMA: | 30.87 | Sell |
| 200-day SMA: | 30.52 | Sell |
| 8-day EMA: | 26.58 | Sell |
| 20-day EMA: | 27.98 | Sell |
| 50-day EMA: | 30.16 | Sell |
| 200-day EMA: | 28.89 | Sell |
Aclaris Therapeutics Earnings Growth & ACRS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.25 per share, an increase next quarter of $0.06 per share, an increase this year of $0.55 per share, and an increase next year of $0.30 per share.
BridgeBio Pharma Earnings Growth & BBIO Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.01 per share, an increase next quarter of $0.16 per share, an increase this year of $0.46 per share, and an increase next year of $0.54 per share.
Aclaris Therapeutics Technical Analysis
| Apr 4 | Apr 5 | Apr 8 | Apr 9 | Apr 10 | Apr 11 | Apr 12 | Apr 15 | Apr 16 | Apr 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
BridgeBio Pharma Technical Analysis
| Apr 4 | Apr 5 | Apr 8 | Apr 9 | Apr 10 | Apr 11 | Apr 12 | Apr 15 | Apr 16 | Apr 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||